This HTML5 document contains 42 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
n11http://dx.doi.org/10.1093/
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q73642062
rdf:type
wikibase:Item
schema:description
wetenschappelijk artikel наукова стаття, опублікована в липні 1997 artículu científicu espublizáu en xunetu de 1997 scientific article published on 01 July 1997 im Juli 1997 veröffentlichter wissenschaftlicher Artikel
p:P577
wds:Q73642062-6A75471C-87F1-4A59-A2B6-29F3CE15F124
wdt:P577
1997-07-01T00:00:00Z
p:P2093
wds:Q73642062-4362FD08-F1B1-497D-97D6-F98E1771A3BB wds:Q73642062-967500C9-0A95-46A2-AE06-24CAAA7D3B70 wds:Q73642062-B955F342-AF1C-4D83-AEE8-6C49DCF7AE52
wdt:P2093
Y Shimizu T Tanishita T Shimazu
rdfs:label
The beta3-adrenergic agonist BRL37344 increases glucose transport into L6 myocytes through a mechanism different from that of insulin The beta3-adrenergic agonist BRL37344 increases glucose transport into L6 myocytes through a mechanism different from that of insulin
skos:prefLabel
The beta3-adrenergic agonist BRL37344 increases glucose transport into L6 myocytes through a mechanism different from that of insulin The beta3-adrenergic agonist BRL37344 increases glucose transport into L6 myocytes through a mechanism different from that of insulin
schema:name
The beta3-adrenergic agonist BRL37344 increases glucose transport into L6 myocytes through a mechanism different from that of insulin The beta3-adrenergic agonist BRL37344 increases glucose transport into L6 myocytes through a mechanism different from that of insulin
p:P50
wds:Q73642062-662659E4-49AF-4D55-9F8F-290420523430
wdt:P50
wd:Q63378259
p:P1476
wds:Q73642062-72460276-CFFF-4FA3-BA50-C065FA714325
wdt:P1476
The beta3-adrenergic agonist BRL37344 increases glucose transport into L6 myocytes through a mechanism different from that of insulin
p:P304
wds:Q73642062-447E0626-47CB-4FE6-AD09-F7FE9359E0F7
wdt:P304
90-95
p:P31
wds:Q73642062-2D9717A2-A075-4260-A156-39AA5A601F6E
wdt:P31
wd:Q13442814
p:P698
wds:Q73642062-CFD9BB97-669F-4A2D-B805-D755DFA9DC3E
wdtn:P698
n12:9276675
wdt:P698
9276675
p:P1433
wds:Q73642062-AAFE16A8-9B85-412F-BE2D-90554E079E95
wdt:P1433
wd:Q6294839
p:P433
wds:Q73642062-9551A8EA-741F-4713-B57B-DF0548998E2B
p:P478
wds:Q73642062-7804D110-AC3B-4933-BC19-934FC63D864F
wdt:P433
1
wdt:P478
122
p:P1104
wds:Q73642062-E387A012-9BEF-4DC0-89BE-B0BE9CECA79C
wdt:P1104
6
p:P356
wds:Q73642062-33B865F6-6251-432D-98E6-3877256DBFBD
wdtn:P356
n11:OXFORDJOURNALS.JBCHEM.A021744
wdt:P356
10.1093/OXFORDJOURNALS.JBCHEM.A021744